The miR-HER2 (human epidermal growth factor receptor 2)-loaded exosomes coated with ligands, which enables them to adhere to HER2 on the surface of human laryngeal carcinoma cells and preferentially enter HER2-positive cells. This evidence concerns the gene ERBB2 and laryngeal carcinoma.